Allergan, INC.
Doing business as Allergan INC
At a glance
Employees100-499
In business sinceNot reported
HeadquartersNorth Chicago, IL
US patents2,302
SAM.gov UEIHC62HHL8JKY3
CAGE code1V0P7
Incorporated inCA
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
2,302 US patents granted 1988–2025, 85 of them in the five years to SEP 2025, including 24 design patents.
Pharmaceuticals 1,379Organic fine chemistry 342Medical technology 326Measurement 73Other special machines 30
- Non-protein Clostridial toxin compositionsUS 12,409,211 · granted SEP 9, 2025
- Process and system for obtaining botulinum neurotoxinUS 12,241,098 · granted MAR 4, 2025
- Method for improving duration of effect of dermal filler treatmentUS 12,208,155 · granted JAN 28, 2025
- Non-protein Clostridial toxin compositionsUS 12,171,816 · granted DEC 24, 2024
- Non-protein clostridial toxin compositionsUS 12,144,847 · granted NOV 19, 2024
Newest 5 shown · Granted to Allergan, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Allergan, INC. | North Chicago | IL | 100–499 | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.